Extrawell Pharmaceutical (HKG:0858) expects to book a profit of between HK$100 million and HK$105 million for the six months ended Sept. 30, compared with a loss a year prior, a Tuesday Hong Kong bourse filing said.
The pharmaceutical company attributed the anticipated swing to profit mainly to a fair value gain on financial assets, comprising investments in convertible bonds, at fair value through profit or loss, compared with a fair value loss in the year-ago period.
Shares of the company closed 4% lower on Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.